Recent Finacing
Recent Raise
Prota Therapeutics is a Melbourne-based biotech developing oral immunotherapies for food allergy remission, advancing lead candidate PRT120 into Phase 3, based on Murdoch Children's Research Institute-derived IP.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Prota Therapeutics.
